Centralized Monitoring: Exploring the Considerations and Challenges of Implementation
Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”.
Innovaderm is proud to have been involved in the development of such a document addressing:
-
1. The key success measures & best practices to ensure a well-connected end-to-end component of risk-based quality management;
2. The positive impact centralized monitoring can have on data quality, patient safety & clinical trial efficiencies;
3. The current & future needs of holistic central monitoring, the potential early-phase study risk reduction, and decrease of preventable errors.
Any questions regarding centralized monitoring and risk-based quality management?
Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.
